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Abstract In response to prolactin (PRL) signaling, transcrip-
tion of the interferon regulatory factor-1 gene (IRF-1) is rapidly
induced during early G1, declines in mid G1, and rises again over
the G1/S transition phase of the cell cycle in Nb2 T cells. Using
chromatin immunoprecipitation assays, we show that histone H4
acetylation increases over a 1.7 kb region of the IRF-1 promoter
in early G1 and again at the G1/S transition in response to PRL
stimulation. These results demonstrate a correlation between
histone H4 hyperacetylation at the IRF-1 promoter and biphasic
transcription of IRF-1 in response to PRL signaling in
vivo. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The packaging of DNA into nucleosomes results in an over-
all repression of gene expression through mechanisms that
may include masking transcription factor interactions with
DNA or creating higher order chromatin structures across
regions of DNA [1,2]. Recently, the characterization of pro-
teins that can modify histones has elucidated how the tran-
scriptional machinery can alter chromatin to modulate gene
expression. Acetylation of histone tails is thought to disrupt
higher order nucleosome structures as well as decreasing the
a⁄nity of histones for DNA, thereby creating a more ‘open’
chromatin architecture that promotes transcription [3^5]. The
discovery that cointegrator or coactivator proteins which pro-
mote transcriptional activation also possess intrinsic histone
acetyltransferase activity (HAT) supports the idea that histone
acetylation and gene transcription are linked [1^3]. These co-
activators, such as CBP/p300, SRCs, and PCAF, are present
in large multi-protein complexes which are recruited to target
promoters through interactions with sequence-speci¢c tran-
scription factors [6,7].
In contrast, proteins that mediate transcriptional repression
are associated with histone deacetylase (HDAC) activity
[4,8,9]. Reversal of histone acetylation can re-establish the
‘closed’ or more condensed chromatin state [1,4]. These
HDACs can be found in large multi-protein complexes tar-
geted to speci¢c promoters through interactions with core-
pressors such as NCoR, SMRT and NuRD, or through se-
quence-speci¢c transcription factors [8,10^12]. Thus the
activities of both transcriptional coactivators and corepressors
can be correlated with changes in histone acetylation. The
recruitment of histone modifying enzymes to a target pro-
moter by sequence-speci¢c factors links changes in histone
acetylation to signals that modulate gene expression.
Transcription of the interferon regulatory factor-1 gene
(IRF-1) is induced in a biphasic manner over a prolactin
(PRL)-induced cell cycle in Nb2 T cells [13]. In this model
system, PRL stimulates greater than 90% of the Nb2 T cells in
a synchronized manner to enter the cell cycle [14]. IRF-1 is an
immediate^early gene, whose transcription dramatically in-
creases from 15 min to 1 h following PRL stimulation. Tran-
scription of IRF-1 is then downregulated by 4 h and upregu-
lated a second time at 8^10 h after PRL stimulation, as the
cells enter S phase. We asked if PRL stimulation of Nb2 T
cells results in changes in histone acetylation at the IRF-1
promoter. Using chromatin immunoprecipitation (ChIP) as-
says, we show increases in acetylated histone H4 on the IRF-1
promoter during both G1 and G1/S transition phase, in par-
allel with the biphasic transcriptional activation of the IRF-1
gene. Further, the increased histone hyperacetylation is seen
throughout the IRF-1 promoter up to 31.7 kb. These results
indicate a role for histone acetylase activity in transcriptional
regulation of the IRF-1 promoter in response to PRL signal-
ing in vivo.
2. Materials and methods
2.1. Cell culture
Nb2 T cells were cultured as previously described [14]. Cells were
made quiescent and synchronized by culturing in medium lacking
newborn calf serum for 18^20 h and were stimulated to enter the
cell cycle by the addition of 50 ng/ml oPRL (NIDDK-20). Under
this culture condition, greater than 90% of the Nb2 T cells are
synchronized in early G1. Upon PRL stimulation, cells traverse G1
over the ¢rst 8 h, G1/S between 8^10 h, S phase from 10^14 h and
complete a cell cycle by 24 h as previously described [14].
2.2. ChIP
Chromatin was prepared from Nb2 T cells (1U107/time point) us-
ing a ChIP kit according to the manufacturer’s protocols (Upstate
Biotechnology). Brie£y, cells were treated with 1% formaldehyde to
cross-link histones to DNA and sonicated to an average length of 600
bp (range 200^1000 bp; data not shown). Cell lysates were diluted 10-
fold in ChIP dilution bu¡er (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris^HCl pH 8.1, 167 mM NaCl, 1 mM AEBSF,
and 1 Wg/Wl aprotinin) and precleared with ssDNA/Protein A beads.
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 2 3 8 5 - 1
*Corresponding author. Fax: (1)-713-798 5780.
E-mail: yulee@bcm.tmc.edu
FEBS 24475 9-1-01
FEBS 24475 FEBS Letters 488 (2001) 91^94
For immunoprecipitation, half of the total lysate was incubated with
anti-acetylated histone H4 antibodies (anti-acH4 Ab) (#06-866, Up-
state Biotechnology) overnight at 4‡C and the other half was analyzed
as total chromatin input. The immunocomplexes were collected with
ssDNA/Protein A beads, the beads were washed, the cross-links were
reversed, and the DNA was recovered by phenol:chloroform extrac-
tion and ethanol precipitation.
PCR was used to detect regions of the IRF-1 promoter in complex
with acetylated histone H4. All reactions were performed using
Ready-To-Go PCR Beads (Amersham Pharmacia Biotech) reconsti-
tuted in a ¢nal volume of 25 Wl containing DNA, 0.5 WM of each
primer, and a [Q-32P]ATP (NEN)-labeled forward primer (300 000
cpm/reaction) as a tracer. PCR reactions were carried out for 30 cycles
at 94‡C for 30 s, 60‡C for 1 min, and 72‡C for 1 min 30 s. The primers
for the IRF-1 promoter were: -0.6 kb region: forward 5P-GAAAT-
TAAGAGTCCCTGCGTCC-3P and reverse 5P-CTCCTAGCCTGCT-
GGTTCATGT-3P ; 31.7 kb region, forward 5P-AGACGGACATTC-
CAGGACAC-3P and reverse 5P-TCTGACACAGCCAAGGAAAA-
3P ; H3.3, forward 5P-GCAAGAGTGCGCCCTCTACTG-3P and re-
verse 5P-GGCCTCACTTGCCTCCTGCAA-3P [15] (Bio-Synthesis,
Inc., Lewisville, TX, USA). All PCR products were detected by auto-
radiography and quantitated using a Storm phosphorimager (Molec-
ular Dynamics, Inc., Sunnyvale, CA, USA). The results are expressed
as the ratio of the immunoprecipitated DNA to the total chromatin
input and plotted as a percent of the maximum ChIP to input ratio.
Data presented are the average þ S.E.M. of n = 3 PCR reactions for
each primer set and are representative of three or four independent
PRL time course experiments. Graphs were generated and statistical
analysis (S.E.M. and ANOVA) was performed using Origin 4.1 soft-
ware (OriginLab Corporation, Northampton, MA, USA).
3. Results
To determine if changes in histone acetylation at the IRF-1
promoter are involved in IRF-1 transcriptional activation in
response to PRL stimulation, ChIP assays were performed
[16]. Brie£y, formaldehyde cross-linked chromatin fragments
were isolated from Nb2 T cells stimulated by PRL to enter the
cell cycle. A 10 h time course covering G1 (1 h) and G1/S (8^
10 h) transition phase of the cell cycle was examined [14].
Chromatin fragments were immunoprecipitated with anti-
acH4 Ab and the precipitated DNA was analyzed by PCR
for the presence of the IRF-1 promoter. Fig. 1 shows a dia-
gram of the IRF-1 promoter and the location of the primers
used for the ChIP assay. Previous nuclear run-on transcrip-
tion studies have shown that the 0.2 kb promoter region me-
diates G1 activation in response to PRL stimulation, while
sequences spanning 0.2 kb and 1.7 kb, in cooperation with
the proximal promoter, mediate G1/S activation of the IRF-1
gene [13,17]. In quiescent Nb2 T cells, a basal level of acety-
lated histone H4 is detected in association with the distal
region of the IRF-1 promoter (Fig. 2A). In response to
PRL signaling, histone H4 acetylation in the 1.7 kb region
of the IRF-1 promoter reproducibly increases by 1 h during
G1, but returns to near basal levels in mid G1, between 2 and
4 h following PRL stimulation (Fig. 2B). An increase in his-
tone H4 acetylation on the IRF-1 promoter is observed again
8^10 h following PRL stimulation as cells enter G1/S phase of
the cell cycle. This biphasic pattern of histone hyperacetyla-
tion at the distal 1.7 kb IRF-1 promoter region parallels the
biphasic IRF-1 transcriptional response to PRL stimulation in
vivo [13].
We next determined if the more central 30.6 kb region of
the IRF-1 promoter also exhibits biphasic changes in histone
H4 acetylation in response to PRL signaling. Interestingly, the
30.6 kb region of the IRF-1 promoter shows a reproducible
increase in histone H4 acetylation at 1 h which persists at 2 h
through early G1 (Fig. 3). Subsequently, histone H4 acetyla-
tion at the IRF-1 promoter returns to basal levels by 4 h and
increases again after 8^10 h of PRL stimulation. Although the
biphasic histone acetylation patterns at both the 30.6 kb and
31.7 kb promoter regions are similar, di¡erences do exist.
Histone hyperacetylation after 2 h PRL at the 31.7 kb
IRF-1 promoter region has already returned to near basal
Fig. 1. Diagram of the IRF-1 promoter and location of PCR prim-
ers. The 0.2 kb region of the IRF-1 promoter is essential for G1
transcription, while G1/S transcription requires sequences extending
to 1.7 kb in collaboration with the proximal 0.2 kb [17]. Primers
used to detect the 30.6 kb and 31.7 kb regions of the IRF-1 pro-
moter are indicated by arrows. The expected sizes of the PCR prod-
uct are given below the arrows. The critical GAS element (3120
bp) and Sp1 element (3200 bp) are indicated.
Fig. 2. Histone H4 acetylation at 31.7 kb of the IRF-1 promoter is
biphasic in response to PRL signaling. ChIP analysis of the IRF-1
gene in Nb2 T cells across a PRL induction time course using anti-
AcH4 Ab. PCR was used to detect the 31.7 kb region of the IRF-
1 promoter. A: Representative PCR reactions from total chromatin
(input) and immunoprecipitated (ChIP) samples (autoradiogram). B:
Radioactive PCR products from an expanded PRL time course
were quantitated, and the data are expressed as the mean þ S.E.M.
of the ratio of ChIP to input material from n = 3 PCR reactions.
Statistical signi¢cance of the data was analyzed by ANOVA
(P = 0.018). The data are representative of three or four independent
PRL time course experiments.
FEBS 24475 9-1-01
M. Book McAlexander, L. Yu-Lee/FEBS Letters 488 (2001) 91^9492
levels (Fig. 2) while that for the 30.6 kb IRF-1 promoter
region is still as highly elevated as the 1 h PRL time point
(Fig. 3). This observation, coupled with the fact that chroma-
tin is sheared to an average length of 600 bp (data not
shown), suggests that distinct chromatin remodeling events
are being detected at the 31.7 kb versus the 30.6 kb IRF-1
promoter in response to PRL stimulation.
The biphasic pattern of histone H4 acetylation at the 30.6
kb and 31.7 kb regions of the IRF-1 promoter is speci¢c to
the IRF-1 gene, as the level of histone H4 acetylation at the
invariant histone H3.3 gene [15] remains essentially un-
changed throughout the PRL induction time course (Fig.
4A). These results are consistent with the constant transcrip-
tion of the histone H3.3 gene in PRL-stimulated Nb2 T cells
[15], and further substantiate the speci¢city of the biphasic
histone H4 acetylation pattern at the IRF-1 promoter in re-
sponse to PRL stimulation in vivo. In addition, a no antibody
(Fig. 4B) and an unrelated antibody (data not shown) control
demonstrate that chromatin does not non-speci¢cally bind to
the ssDNA/Protein A beads during immunoprecipitation, thus
demonstrating the speci¢city of the ChIP assay for acetylated
histones.
4. Discussion
Chromatin modi¢cation has been shown to play an impor-
tant role in transcriptional regulation. In this paper we show
that changes in histone H4 acetylation at the IRF-1 promoter
parallel the biphasic pattern of PRL-induced transcription of
the IRF-1 gene in vivo. Using the ChIP assay, we show that
histone H4 acetylation at the IRF-1 promoter increases in
response to PRL signaling concomitant with the initial rise
of transcription as cells enter G1. Histone H4 acetylation sub-
sequently decreases with kinetics similar to the downregula-
tion of IRF-1 transcription in mid G1. Histone H4 acetylation
levels at the IRF-1 promoter increase again at the G1/S tran-
sition, coincident with the second rise in IRF-1 gene tran-
scription. This biphasic change in histone H4 acetylation is
observed as far as 1.7 kb upstream of the transcriptional start
site of the IRF-1 gene. These results show a strong correlation
between the pattern of histone acetylation and biphasic tran-
scription of the IRF-1 gene in vivo, implicating histone mod-
i¢cation and changes in chromatin structure in transcriptional
regulation of the IRF-1 gene.
Maximal induction of IRF-1 transcription in response to
PRL signaling requires multiple elements within the 1.7 kb
promoter. The minimal PRL-responsive elements are located
in the proximal 200 bp of the IRF-1 promoter, including a
critical GAS element at 3120 bp [13,17,18]. PRL-inducible
Stat1 interaction with the GAS element is required for tran-
scriptional activation of the IRF-1 gene [18,19]. The trans-
activation potential of Stat1 at the 1.7 kb native IRF-1 pro-
moter is further enhanced by interaction with the coactivator
CBP/p300 [20]. The Stat1/CBP/p300 interactions may be one
mechanism by which HAT activity is recruited to the IRF-1
promoter. Additionally, an Sp1 site at 3200 bp of the IRF-1
promoter is required for maximal G1 transcription of the
IRF-1 gene (M.B. McAlexander and L.-y. Yu-Lee, in prepa-
ration). Sp1 can further enhance Stat1-mediated transcription-
Fig. 4. Histone H4 acetylation does not change within the invariant
histone H3.3 gene in response to PRL signaling. A: The same ChIP
samples as in Fig. 2 were assayed for the invariant histone H3.3
gene using PCR. Radioactive PCR products from an expanded
PRL time course were quantitated, and the data are expressed as
the mean þ S.E.M. of the ratio of ChIP to input material from n = 3
PCR reactions. The data are representative of three or four inde-
pendent PRL time course experiments. B: A representative PCR re-
action of invariant histone H3.3 from total chromatin (input) and
immunoprecipitated (ChIP) samples using anti-AcH4 antibody
(lanes 1 and 2) or no antibody control (lane 3) as indicated (autora-
diogram). Lanes 1 and 3, 8 h PRL; lane 2, 10 h PRL.
Fig. 3. Histone H4 acetylation at 30.6 kb of the IRF-1 promoter is
biphasic in response to PRL signaling. The same ChIP samples as
in Fig. 2 were assayed for the 30.6 kb region of the IRF-1 pro-
moter using PCR. A: Representative PCR reactions from total
chromatin (input) and immunoprecipitated (ChIP) samples (ethid-
ium-bromide-stained gel). B: Radioactive PCR products from an ex-
panded PRL time course were quantitated, and the data are ex-
pressed as the mean þ S.E.M. of the ratio of ChIP to input material
from n = 3 PCR reactions. Statistical signi¢cance of the data was an-
alyzed by ANOVA (P = 0.032). The data are representative of three
or four independent PRL time course experiments.
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al activity by recruiting its own coactivator complex CRSP
[21], the coactivator CBP [22], and components of the basal
transcription machinery to regulate IRF-1 transcription. Our
data suggest that during G1, PRL-inducible Stat1 and consti-
tutively bound Sp1 work together to recruit HAT activities
which increase histone H4 acetylation throughout the 1.7 kb
promoter to mediate IRF-1 transcription.
Which factors act to reverse H4 acetylation and thereby
shut down IRF-1 transcription in mid G1 are as yet unde-
¢ned. The loss of Stat1 binding to the IRF-1 GAS at 4 h after
PRL stimulation [13], due to either nuclear tyrosine phospha-
tase or proteasome activity [23,24], may ultimately lead to a
loss of HAT activity at the IRF-1 promoter. It is also possible
that PRL-induced Stat5 squelches limiting amounts of the
coactivator CBP/p300 and thus antagonizes Stat1-mediated
activation of the IRF-1 promoter [20]. Alternatively, Sp1
could recruit a deacetylase [11] to the IRF-1 promoter, revers-
ing histone H4 acetylation thereby shutting down promoter
activity. Experiments are underway to distinguish among
these possibilities.
IRF-1 transcription at G1/S phase of the cell cycle is also
correlated with an increase in histone H4 acetylation on the
IRF-1 promoter (Figs. 2 and 3). Previous studies have shown
that G1/S transcription requires IRF-1 promoter sequences
beyond 30.2 kb extending to 31.7 kb [13]. Recent studies
have shown that the 30.6 kb IRF-1 promoter region is su⁄-
cient to mediate the G1/S response (M.B. McAlexander and
L.-y. Yu-Lee, unpublished observations). Further, functional
interactions between promoter distal elements and the prox-
imal GAS element are required for PRL-induced IRF-1 gene
transcription, as the region encompassing 30.2 to 31.7 kb is
not PRL-responsive when taken out of context of the native
0.2 kb IRF-1 promoter [17]. A Stat-like factor binds the IRF-
1 GAS during G1/S transition in PRL-stimulated Nb2 T cells
[19], but how this factor is involved in G1/S transcription of
the IRF-1 gene is currently unknown. Histone H4 acetylation
at the IRF-1 promoter extends from 30.6 kb to 31.7 kb
(Figs. 2 and 3), indicating that the entire 1.7 kb region of
the IRF-1 promoter is targeted for PRL activation in both
early G1 and during G1/S transition. Although studies at oth-
er promoters have shown a more localized region of hyper-
acetylation in conjunction with gene transcription [25,26], the
acetylation of a broad region of the IRF-1 promoter agrees
with data from the yeast HO gene promoter which is hyper-
acetylated over a 1 kb region in a temporal manner that
correlates with HO transcription [27]. Interestingly, the tem-
poral patterns of histone acetylation at the 30.6 kb and 31.7
kb IRF-1 promoter regions are similar but not identical. The
2 h time point shows a higher level of histone H4 acetylation
in the 30.6 kb region (Fig. 3B) than in the 31.7 kb region
(Fig. 2B), indicating possible temporal di¡erences in chroma-
tin remodeling enzyme activities in the distal promoter when
compared to the more central region of the IRF-1 promoter.
This may provide insight into mid-G1 transcriptional down-
regulation of IRF-1, which is currently under investigation.
Our studies demonstrate the involvement of HAT activity
and chromatin remodeling at the IRF-1 promoter in PRL
stimulation of IRF-1 gene transcription at two distinct phases
of the cell cycle. Further ChIP studies employing antibodies
against speci¢c transcription factors [28,29] and acetylated
histone H3 should elucidate how promoter-speci¢c factors,
together with chromatin remodeling and/or cell cycle regu-
lated factors, coordinate the transcription of the IRF-1 gene
in vivo.
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